Article Type
Corrigendum
Published
The authors wish to make the following corrections to their article: Clements JN. Diabetes: how to manage chronic kidney disease. Drugs Context. 2022;11:2021-9-10. https://doi.org/10.7573/dic.2021-9-10
Corrigendum
The authors wish to make the following corrections to their article: Clements JN. Diabetes: how to manage chronic kidney disease. Drugs Context. 2022;11:2021-9-10. https://doi.org/10.7573/dic.2021-9-10
Review
This narrative review provides the most up-to-date information regarding existing and new pharmacotherapy for the management of chronic kidney disease amongst people with diabetes, specifically type 2 diabetes.
Review
This narrative review summarizes the role of renin–angiotensin–aldosterone system inhibitors in acute and chronic heart failure and chronic kidney disease.
Review
This article reviews the expanding clinical applicability of chloroquine and related drugs includes rheumatological and cardiovascular disorders (CVD), chronic kidney disease (CKD), oncology, and a variety of nonmalarial infections.
Original Research
Autosomal dominant polycystic kidney disease (ADPKD) is a progressive genetic disorder characterized by the development of numerous kidney cysts that result in kidney failure. The results of this study suggest that distribution of patients by age at transition to next stage may be useful for identification of ADPKD patients at risk of rapid progression.